Light Mode
$0.2403 ↓ -0.0255 (-9.60%) Trading Down from the previous close of $0.2658, and at the day’s high of $0.2403
-0.04 (-15.68%) / 6M
Momentum, market sentiment, and recent alerts
AGNPF reads n/a: the 12-month move is +284.5%.
No alerts for AGNPF in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Grey Matters Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.